Loading clinical trials...

Pilot Study of Maintenance Therapy With Intravenous AMANTADINE | Clinical Trials | Clareo Health

UNKNOWNNA

Pilot Study of Maintenance Therapy With Intravenous AMANTADINE

Maintenance Therapy of Intravenous Amantadine in Patients With Idiopathic Parkinson Disease Who Are Not Optimally Treated With Anti Parkinson Medications

NCT01190553•Rabin Medical Center

View on ClinicalTrials.gov

Summary

This is a pilot study for Maintenance Intravenous Treatment with AMANTADINE in patient with PARKINSON'S Disease who are not well balanced with medical treatment.

Eligibility

Age

30 - 80 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Patients with idiopathic Parkinson disease
•Age\<80
•Patients with no motor improvement under optimal treatment with anti parkinson medications
•Patients with moderate to severe dyskinesias
•Patients with PD with side effects who can not tolerate anti parkinson medications

Exclusion Criteria

•Age\>80
•Patients with Parkinson syndromes, vascular parkinsonism or drug-induced parkinsonism
•Patients with PD who developed adverse reactions to oral amantadine
•Contraindication of amantadine treatment

Key Dates

Start Date

November 1, 2010

Primary Completion Date

December 1, 2011

Completion Date

June 1, 2012

Last Updated

October 13, 2010

Enrollment

ESTIMATED participants

Conditions

Parkinson Disease

Interventions

Amantadine

DRUG

Characterizing the Pathophysiological Role of the Pallido-thalamocortical Motor Pathway in Parkinson's Disease.

NCT06692920

Parkinson Disease

View study

RECRUITINGPHASE1

[18F]F-DOPA Imaging in Patients With Autonomic Failure

NCT04246437

Autonomic FailurePure Autonomic Failure+3 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 13, 2010Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Pilot Study of Maintenance Therapy With Intravenous AMANTADINE

Inclusion Criteria

Exclusion Criteria

Characterizing the Pathophysiological Role of the Pallido-thalamocortical Motor Pathway in Parkinson's Disease.

[18F]F-DOPA Imaging in Patients With Autonomic Failure

Montelukast in Parkinson Disease

Exercise for Cognitive Excellence in Parkinson's Disease

SAD Study in Patients With Parkinson's Disease and Motor Fluctuations

The Effect of Functional Rotational Exercises on Fall Risk and Mobility in Parkinson's Disease Patients